Who
Craig Malzahn
Chief Technology Officer
Company insider
Files Form 4 as: Chief Technology Officer, Regenxbio.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 1 Sep 2025
- Last trade
- 1 Sep 2026
- Last filed
- 3 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 3 Sep 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code F | $2,181234 at $9.32 | filing |
| 1 Sep 2026filed 3 Sep 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code F | $2,181234 at $9.32 | filing |
| 6 Jan 2026filed 8 Jan 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —65,847 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,402 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | RGNX Regenxbiooption or derivative · Biotechnology | SEC FORM 4 Code A | —35,402 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code A | —65,847 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code F | $18K1,238 at $14.40 | filing |
| 2 Jan 2026filed 6 Jan 2026 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code F | $18K1,238 at $14.40 | filing |
| 1 Sep 2025filed 3 Sep 2025 | RGNX RegenxbioBiotechnology | SEC FORM 4 Code F | $2,090234 at $8.93 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.